Exact Mass: 456.2545
Exact Mass Matches: 456.2545
Found 500 metabolites which its exact mass value is equals to given mass value 456.2545
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Phytyl diphosphate
Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids. [HMDB]. Phytyl diphosphate is found in many foods, some of which are highbush blueberry, wild leek, evergreen huckleberry, and allium (onion). Phytyl diphosphate participates in biosynthesis of steroids as well as porphyrin and metabolism. Phytyl diphosphate is produced from Geranylgeranyl diphosphate in biosynthesis of steroids.
D1927
Lucidenic acid F
Lucidenic acid F is found in mushrooms. Lucidenic acid F is a constituent of Ganoderma lucidum (reishi). Constituent of Ganoderma lucidum (reishi). Lucidenic acid F is found in mushrooms.
Lucidenolactone
Metabolite of Ganoderma lucidum (reishi). Lucidenolactone is found in mushrooms. Lucidenolactone is found in mushrooms. Metabolite of Ganoderma lucidum (reishi
Sulfolithocholic acid
Sulfolithocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID:11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.
Rigin
Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin. [HMDB] Rigin (glycyl-L-glutaminyl-L-prolyl-L-arginine) is a tetrapeptide with functions similar to those of tuftsin.
N-[(2S)-1-[[(2S)-1-Amino-1-oxopropan-2-yl]amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N'-hydroxy-2-(2-methylpropyl)butanediamide
Zatebradine
1-Acetyl-17-(3,3-dimethyloxiranyl)-1,2,3,8a,9,14,15,16a-octahydro-9-methyl-13,16-methano-8H,16H-pyrrolo[2,3:2,3]pyrido[4,3-o]quinindoline
20(21)-Dehydrolucidenic acid A
20(21)-Dehydrolucidenic acid A is a natural product found in Ganoderma sinense and Ganoderma lucidum with data available.
[(3R,4S,8S,8aS)-3-hydroxy-6,8a-dimethyl-8-[(Z)-2-methylbut-2-enoyl]oxy-3-propan-2-yl-1,2,3a,4,5,8-hexahydroazulen-4-yl] 4-hydroxybenzoate
11-O-acetyl-8-epi-torilolone 8-O-beta-D-glucopyranoside
(7R,8R)-7-hydroxy-3-(4-hydroxy-2-methyl-6-oxocyclohexenyl)-7-methyl-8-(3-methyl-2-oxononyl)-7,8-dihydro-isochromene-6-one|cohaerin F
(1S,4R,7S,8aR)-4-((2E,4E)-6,8-dimethyldeca-2,4-dienyloxy)-8a-methyl-6-oxo-7-(3-oxoprop-1-en-2-yl)-1,2,3,4,6,7,8,8a-octahydronaphthalene-1-carboxylic acid|07H239-A
8-methoxy-9-hydroxy-3,10-diheptyl-2H,5H-pyran[5,6-c][1]benzopyran-2,5-dione|fordianin B
5,7-dihydroxy-4-(1-hydroxypropyl)-6-(2-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin C
17-formyl-19-hydroxy-11-methoxy-3,15,20-trimethyl-corynane-16-carboxylic acid methyl ester
(-)-5,7-dihydroxy-4-(1S-hydroxypropyl)-6-(3-methyl-1-oxobutyl)-8-(3,7-dimethyl-2,6-octadienyl)-2H-benzopyran-2-one|kayeassamin D
methyl (2beta,12beta,19alpha)-1-[(2E)-3-phenylprop-2-enoyl]aspidospermidin-21-oate|N1-cinnamoyl-12-demethoxycylindrocarine
3-[(2E,6E,10E)-11-carboxy-3,7,15-trimethyl-2,6,10,14-hexadecatetraenyl]-4,5-dihydroxybenzoic acid
9-Hydroxy-gamma-geraniol-1-O-(6-acetyl-3-angelyl)-beta-D-glucopyranoside|9-Hydroxy-gamma-geraniol-1-O-<6-acetyl-3-angelyl>-beta-D-glucopyranoside
Estra-1,3,5(10)-triene-3,16|A,17|A-triol tripropionate
2,6-diheptyl-3,6-dihydroxy-7-methoxy-dibenzofuran-1,4-dione|fordianaquinone B
Lucidenic acid F
Lucidenic acid F is a triterpenoid. Lucidenic acid F is a natural product found in Ganoderma lucidum with data available.
C27H36O6_1-Naphthalenecarboxylic acid, 8-(benzoyloxy)decahydro-7-hydroxy-5-[(3Z)-5-hydroxy-3-methyl-3-penten-1-yl]-1,4a-dimethyl-6-methylene
C27H36O6_Benzoic acid, 4-hydroxy-, (3R,4S,8S,8aS)-1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2Z)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
C27H36O6_Benzoic acid, 4-hydroxy-, 1,2,3,3a,4,5,8,8a-octahydro-3-hydroxy-6,8a-dimethyl-3-(1-methylethyl)-8-[[(2E)-2-methyl-1-oxo-2-buten-1-yl]oxy]-4-azulenyl ester
3a-Sulfooxy-5b-cholanic acid
BA-139-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-139-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.
Ala Asn Pro Arg
Ala Asn Arg Pro
Ala Pro Asn Arg
Ala Pro Arg Asn
Ala Arg Asn Pro
Ala Arg Pro Asn
Asp Ile Ile Pro
Asp Ile Leu Pro
Asp Ile Pro Ile
Asp Ile Pro Leu
Asp Leu Ile Pro
Asp Leu Leu Pro
Asp Leu Pro Ile
Asp Leu Pro Leu
Asp Pro Ile Ile
Asp Pro Ile Leu
Asp Pro Leu Ile
Asp Pro Leu Leu
Glu Ile Pro Val
Glu Ile Val Pro
Glu Leu Pro Val
Glu Leu Val Pro
Glu Pro Ile Val
Glu Pro Leu Val
Glu Pro Val Ile
Glu Pro Val Leu
Glu Val Ile Pro
Glu Val Leu Pro
Glu Val Pro Ile
Glu Val Pro Leu
Phe Pro Pro Pro
Gly Pro Gln Arg
Gly Pro Arg Gln
Gly Gln Pro Arg
Gly Gln Arg Pro
Gly Arg Pro Gln
Gly Arg Gln Pro
His Ile Ser Thr
His Ile Thr Ser
His Leu Ser Thr
His Leu Thr Ser
His Ser Ile Thr
His Ser Leu Thr
His Ser Thr Ile
His Ser Thr Leu
His Thr Ile Ser
His Thr Leu Ser
His Thr Ser Ile
His Thr Ser Leu
His Thr Thr Val
His Thr Val Thr
His Val Thr Thr
Ile Asp Ile Pro
Ile Asp Leu Pro
Ile Asp Pro Ile
Ile Asp Pro Leu
Ile Glu Pro Val
Ile Glu Val Pro
Ile His Ser Thr
Ile His Thr Ser
Ile Ile Asp Pro
Ile Ile Pro Asp
Ile Leu Asp Pro
Ile Leu Pro Asp
Ile Met Pro Pro
Ile Asn Asn Pro
Ile Pro Asp Ile
Ile Pro Asp Leu
Ile Pro Glu Val
Ile Pro Ile Asp
Ile Pro Leu Asp
Ile Pro Met Pro
Ile Pro Asn Asn
Ile Pro Pro Met
Ile Pro Val Glu
Ile Ser His Thr
Ile Ser Thr His
Ile Thr His Ser
Ile Thr Ser His
Ile Val Glu Pro
Ile Val Pro Glu
Lys Asn Pro Val
Lys Asn Val Pro
Lys Pro Asn Val
Lys Pro Val Asn
Lys Val Asn Pro
Lys Val Pro Asn
Leu Asp Ile Pro
Leu Asp Leu Pro
Leu Asp Pro Ile
Leu Asp Pro Leu
Leu Glu Pro Val
Leu Glu Val Pro
Leu His Ser Thr
Leu His Thr Ser
Leu Ile Asp Pro
Leu Ile Pro Asp
Leu Leu Asp Pro
Leu Leu Pro Asp
Leu Met Pro Pro
Leu Asn Asn Pro
Leu Asn Pro Asn
Leu Pro Asp Ile
Leu Pro Asp Leu
Leu Pro Glu Val
Leu Pro Ile Asp
Leu Pro Leu Asp
Leu Pro Met Pro
Leu Pro Asn Asn
Leu Pro Pro Met
Leu Pro Val Glu
Leu Ser His Thr
Leu Ser Thr His
Leu Thr His Ser
Leu Thr Ser His
Leu Val Glu Pro
Leu Val Pro Glu
Met Ile Pro Pro
Met Leu Pro Pro
Met Pro Ile Pro
Met Pro Leu Pro
Met Pro Pro Ile
Met Pro Pro Leu
Asn Ala Pro Arg
Asn Ala Arg Pro
Asn Ile Asn Pro
Asn Ile Pro Asn
Asn Lys Pro Val
Asn Lys Val Pro
Asn Pro Ala Arg
Asn Pro Lys Val
Asn Pro Arg Ala
Asn Pro Val Lys
Asn Arg Ala Pro
Asn Arg Pro Ala
Asn Val Lys Pro
Asn Val Pro Lys
Pro Ala Asn Arg
Pro Ala Arg Asn
Pro Asp Ile Ile
Pro Asp Ile Leu
Pro Asp Leu Ile
Pro Asp Leu Leu
Pro Glu Ile Val
Pro Glu Leu Val
Pro Glu Val Ile
Pro Glu Val Leu
Pro Phe Pro Pro
Pro Gly Gln Arg
Pro Gly Arg Gln
Pro Ile Asp Ile
Pro Ile Asp Leu
Pro Ile Glu Val
Pro Ile Ile Asp
Pro Ile Leu Asp
Pro Ile Met Pro
Pro Ile Pro Met
Pro Ile Val Glu
Pro Lys Asn Val
Pro Lys Val Asn
Pro Leu Asp Ile
Pro Leu Asp Leu
Pro Leu Glu Val
Pro Leu Ile Asp
Pro Leu Leu Asp
Pro Leu Met Pro
Pro Leu Pro Met
Pro Leu Val Glu
Pro Met Ile Pro
Pro Met Leu Pro
Pro Met Pro Ile
Pro Met Pro Leu
Pro Asn Ala Arg
Pro Asn Lys Val
Pro Asn Arg Ala
Pro Asn Val Lys
Pro Pro Phe Pro
Pro Pro Ile Met
Pro Pro Leu Met
Pro Pro Met Ile
Pro Pro Met Leu
Pro Pro Pro Phe
Pro Gln Gly Arg
Pro Gln Arg Gly
Pro Arg Ala Asn
Pro Arg Gly Gln
Pro Arg Asn Ala
Pro Arg Gln Gly
Pro Val Glu Ile
Pro Val Glu Leu
Pro Val Ile Glu
Pro Val Lys Asn
Pro Val Leu Glu
Pro Val Asn Lys
Gln Gly Pro Arg
Gln Gly Arg Pro
sulfolithocholic acid
D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids
Gln Pro Gly Arg
Gln Pro Arg Gly
Gln Arg Gly Pro
Gln Arg Pro Gly
Gln Val Pro Asn
Arg Ala Asn Pro
Arg Ala Pro Asn
Arg Gly Pro Gln
Arg Gly Gln Pro
Arg Asn Ala Pro
Arg Asn Pro Ala
Arg Pro Ala Asn
Arg Pro Gly Gln
Arg Pro Asn Ala
Arg Pro Gln Gly
Arg Gln Gly Pro
Arg Gln Pro Gly
Ser Ile Thr His
Ser Leu His Thr
Ser Leu Thr His
Ser Thr His Ile
Ser Thr His Leu
Ser Thr Ile His
Ser Thr Leu His
Thr His Ile Ser
Thr His Leu Ser
Thr His Ser Ile
Thr His Ser Leu
Thr His Thr Val
Thr His Val Thr
Thr Ile His Ser
Thr Ile Ser His
Thr Leu His Ser
Thr Leu Ser His
Thr Ser His Ile
Thr Ser His Leu
Thr Ser Ile His
Thr Ser Leu His
Thr Thr His Val
Thr Thr Val His
Thr Val His Thr
Thr Val Thr His
Val Glu Ile Pro
Val Glu Leu Pro
Val Glu Pro Ile
Val Glu Pro Leu
Val His Thr Thr
Val Ile Glu Pro
Val Ile Pro Glu
Val Lys Asn Pro
Val Lys Pro Asn
Val Leu Glu Pro
Val Leu Pro Glu
Val Asn Lys Pro
Val Asn Pro Lys
Val Asn Pro Gln
Val Asn Gln Pro
Val Pro Glu Ile
Val Pro Glu Leu
Val Pro Ile Glu
Val Pro Lys Asn
Val Pro Leu Glu
Val Pro Asn Lys
Val Pro Asn Gln
Val Pro Gln Asn
Val Gln Asn Pro
Val Gln Pro Asn
Val Thr His Thr
Val Thr Thr His
PG(14:0/0:0)[U]
Lucidenolactone
Zatebradine
C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D020011 - Protective Agents > D002316 - Cardiotonic Agents D002317 - Cardiovascular Agents
(4S)-3-[(2S,4S)-4-azido-4-[(2S,4S)-5-oxo-4-propan-2-yloxolan-2-yl]-2-propan-2-ylbutanoyl]-4-benzyl-1,3-oxazolidin-2-one
1,3-Benzodioxole,5-[bis[2-(2-butoxyethoxy)ethoxy]methyl]-
2,2-[(1-methylethylidene)bis[4,1-phenyleneoxy(1-methyl-2,1-ethanediyl)oxymethylene]]bis-Oxirane
butyl 2-methylprop-2-enoate,butyl prop-2-enoate,methyl 2-methylprop-2-enoate,2-methylprop-2-enoic acid
Pipendoxifene
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent
N-[1-[(1-amino-1-oxopropan-2-yl)amino]-3-naphthalen-2-yl-1-oxopropan-2-yl]-N-hydroxy-2-(2-methylpropyl)butanediamide
n4-Hydroxy-2-isobutyl-n1-(9-oxo-1,8-diaza-tricyclo[10.6.1.013,18]nonadeca-12(19),13,15,17-tetraen-10-yl)-succinamide
N-[(1S)-2-{[(1R)-2-(benzyloxy)-1-cyano-1-methylethyl]amino}-1-(cyclohexylmethyl)-2-oxoethyl]morpholine-4-carboxamide
1-tetradecanoyl-sn-glycero-3-phospho-(1-sn-glycerol)
[(2R)-1-[[(2S)-2,3-dihydroxypropoxy]-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] tetradecanoate
Rhodamine B hydrazide
D019995 - Laboratory Chemicals > D007202 - Indicators and Reagents > D012235 - Rhodamines
Xyloketal A
A xyloketal with formula C27H36O6. It was initially isolated from the mangrove fungus Xylaria sp. from the South China sea coast.
Strongylophorine-26
A diterpenoid that is 15,17-epoxypodocarpan-15-one substituted by a hydroxy group at position 13, methyl groups at positions 8 and 13 and a (5-methoxy-3,6-dioxocyclohexa-1,4-dien-1-yl)methyl group at position 14 (the 13alpha,14beta stereoisomer). Isolated from the marine sponge Petrosia corticata, it exhibits antineoplastic activity.
2-[4-[2-(3,5-dimethoxyanilino)-2-oxoethyl]-1-piperazinyl]-N-(4-ethoxyphenyl)acetamide
8-benzoyloxy-7-hydroxy-5-[(Z)-5-hydroxy-3-methylpent-3-enyl]-1,4a-dimethyl-6-methylidene-3,4,5,7,8,8a-hexahydro-2H-naphthalene-1-carboxylic acid
N-[(S)-[(1S,2R)-1-methyl-2-[(2R)-1-oxo-1-[(phenylmethyl)amino]propan-2-yl]cyclopropyl]-phenylmethyl]carbamic acid (phenylmethyl) ester
N-[2-(3,4-dimethoxyphenyl)ethyl]-1-[(3,4-dimethoxyphenyl)methyl]-N-methyl-3-piperidinecarboxamide
[(1S,5R)-8-methyl-8-[(4-phenylphenyl)methyl]-8-azoniabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate
(1R,9S,10S,11S)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[(1S)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
1-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]-3-(4-methoxyphenyl)urea
1-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-(methylaminomethyl)-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-10-yl]-3-(4-methoxyphenyl)urea
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-(5-pyrimidinyl)-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-1-methyl-3-propan-2-ylurea
(1S,9R,10R,11R)-5-(cyclohexen-1-yl)-10-(hydroxymethyl)-N-(3-morpholin-4-ylpropyl)-6-oxo-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
1-[(1S)-1-(hydroxymethyl)-7-methoxy-9-methyl-1-propyl-2-spiro[1,3-dihydropyrido[3,4-b]indole-4,3-azetidine]yl]-2-(4-morpholinyl)ethanone
2-(dimethylamino)-1-[(1R)-1-(hydroxymethyl)-7-methoxy-1-(4-oxanylmethyl)-2-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]ethanone
1-[(1R)-1-(hydroxymethyl)-7-methoxy-2,9-dimethyl-1-spiro[1,3-dihydropyrido[3,4-b]indole-4,4-piperidine]yl]-2-(4-morpholinyl)ethanone
(2S)-N-[3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-2-[[4-(2,5-dioxopyrrolidin-1-yl)-2-sulfanylbutanoyl]amino]-4-methylpentanamide
(5S,12R)-dihydroxy-(6R)-cysteinyl-(7E,9E,14Z)-icosatrienoate
[3-[2,3-Dihydroxypropoxy(hydroxy)phosphoryl]oxy-2-hydroxypropyl] tetradecanoate
(E)-3,7,11,15-tetramethylhexadec-2-en-1-yl diphosphate
(12R)-hydroxy-10,11-dihydroleukotriene E4(1-)
An icosanoid anion that is the conjugate base of (12R)-hydroxy-10,11-dihydroleukotriene E4, obtained by deprotonation of the carboxy group; major species at pH 7.3.
TAPI-0
TAPI-0 is a TACE (TNF-α converting enzyme; ADAM17) inhibitor with an IC50 of 100 nM. TAPI-0 is a MMP inhibitor and also attenuates TNF-α processing[1][2].